Key Takeaways Vermont’s fledgling drug importation law has undergone preliminary savings analysis, with uninspiring projections of a 3.8% drug cost savings rate The importation program is unable to consider infused or biologic products, severely limiting the scope The state’s analysis admitted that the state Medicaid program is likely already receiving…
Vermont’s Drug Importation: Rubber, Meet Road
